Literature DB >> 6145138

Pain relief by somatostatin in attacks of cluster headache.

F Sicuteri1, P Geppetti, S Marabini, F Lembeck.   

Abstract

The pain relieving effect of somatostatin treatment during 72 attacks of cluster headache in 8 male patients was compared to treatment with ergotamine or placebo in a double-blind study. Infusion of somatostatin (25 micrograms/min for 20 min i.v.) reduced the maximal pain intensity and the duration of pain significantly compared to placebo treatment, and to a degree comparable to ergotamine tartrate treatment (250 micrograms i.m.). The results obtained provide new information concerning the possible mechanism of cluster headache attacks and suggest a new therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145138     DOI: 10.1016/0304-3959(84)90048-4

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  14 in total

Review 1.  The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.

Authors:  D P Beltrutti; S Moessinger; G Varrassi
Journal:  Curr Rev Pain       Date:  2000

2.  Inhibition of ASIC-Mediated Currents by Activation of Somatostatin 2 Receptors in Rat Dorsal Root Ganglion Neurons.

Authors:  Ting-Ting Liu; Shuang Wei; Ying Jin; Chun-Yu Qiu; Wang-Ping Hu
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

Review 3.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

4.  Effects of somatostatin on the responses of rostrally projecting spinal dorsal horn neurons to noxious stimuli in cats.

Authors:  Sung Jun Jung; Su-Hyun Jo; Sanghyuck Lee; Eunhui Oh; Min-Seok Kim; Woo Dong Nam; Seog Bae Oh
Journal:  Korean J Physiol Pharmacol       Date:  2008-10-31       Impact factor: 2.016

Review 5.  Modulation of pain transmission by G-protein-coupled receptors.

Authors:  Hui-Lin Pan; Zi-Zhen Wu; Hong-Yi Zhou; Shao-Rui Chen; Hong-Mei Zhang; De-Pei Li
Journal:  Pharmacol Ther       Date:  2007-09-22       Impact factor: 12.310

Review 6.  Management of trigeminal autonomic cephalgias and hemicrania continua.

Authors:  Manjit S Matharu; Christopher J Boes; Peter J Goadsby
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 7.  Cluster headache pathophysiology - insights from current and emerging treatments.

Authors:  Diana Y Wei; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2021-03-29       Impact factor: 42.937

Review 8.  Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?

Authors:  Li-Chun Lin; Etienne Sibille
Journal:  Front Pharmacol       Date:  2013-09-09       Impact factor: 5.810

9.  Italian guidelines for primary headaches: 2012 revised version.

Authors:  Paola Sarchielli; Franco Granella; Maria Pia Prudenzano; Luigi Alberto Pini; Vincenzo Guidetti; Giorgio Bono; Lorenzo Pinessi; Massimo Alessandri; Fabio Antonaci; Marcello Fanciullacci; Anna Ferrari; Mario Guazzelli; Giuseppe Nappi; Grazia Sances; Giorgio Sandrini; Lidia Savi; Cristina Tassorelli; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2012-05       Impact factor: 7.277

10.  Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: expression, trafficking and possible role in pain.

Authors:  Tie-Jun Sten Shi; Qiong Xiang; Ming-Dong Zhang; Swapnali Barde; Ylva Kai-Larsen; Kaj Fried; Anna Josephson; Laura Glück; Sergey M Deyev; Andrei V Zvyagin; Stefan Schulz; Tomas Hökfelt
Journal:  Mol Pain       Date:  2014-02-13       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.